National Cancer Institute; Cancellation of Meeting
---
identifier: "/us/fr/2023-28371"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Cancer Institute; Cancellation of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2023-28371"
section_name: "National Cancer Institute; Cancellation of Meeting"
positive_law: false
currency: "2023-12-26"
last_updated: "2023-12-26"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2023-28371"
document_type: "notice"
publication_date: "2023-12-26"
agencies:
- "Health and Human Services Department"
- "National Institutes of Health"
fr_citation: "88 FR 88930"
fr_volume: 88
---
# National Cancer Institute; Cancellation of Meeting
Notice is hereby given of the cancellation of the National Cancer Institute Special Emphasis Panel, SEP-11: NCI Clinical and Translational Cancer Research, March 7, 2024, 10:00 a.m. to March 7, 2024, 1:30 p.m., National Cancer Institute Shady Grove, Resources and Training Review Branch, Division of Extramural Activities, 9609 Medical Center Drive, Room 7W238, Rockville, Maryland, 20850 which was published in the *Federal Register* on December 20, 2023, FR Doc. 2023-27963, 88 FR 88100.
This meeting is being cancelled and will be rescheduled with a new contact person.
Dated: December 20, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.